Global Alzheimer's Platform Innovations Pbc
Drive innovation in Alzheimer's Disease therapies and the clinical trial process.
Based in DC
AI Overview
With $192K in lobbying spend across 9 quarterly filings, Global Alzheimer's Platform Innovations Pbc is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2022 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $96K |
| 2023 | $96K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Global Alzheimer's Platform Innovations Pbc disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Medicare/Medicaid, Health Issues, Budget/Appropriations
Issues related to improving the clinical trial process for Alzheimers therapies and expediting the search for a cure.
Issues related to diversity in clinical trials, Alzheimers research, and ARPA-H.
Issues related to Medicare coverage of Alzheimers treatments.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.